Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012
Aggregate Shares	3,376,975
Shares Price	1.00%
Beneficial Conversion Feature	$ 202,305
Preferred Stock Outstanding	1,000,000	65,271	1,000,000
Deemed Dividends		92,916
Preferred Stock Dividends	7.00%
Common Stock Issuable	1,295,738
Beneficial Conversion Feature Related to Incremental Shares	1,330,417
Stock-Based Compensation Expense	330,021	259,409
Common Stock Warrant Issued	6,934,784
Warrants Exercise Purchase	8,125,750
Warrants Exercise Price Per Share	$ 0.25
Salary expense	87,500
Series C Preferred Stock
Deemed Dividends	92,916
Stock Options [Member]
Weighted Average Fair Value	$ 1.20	$ 5.27
Selling, General And Administrative Expenses	312,444	259,409
Stock-Based Compensation Expense	2,916,160
Weighted Average Remaining Period	2 years 3 months 18 days
Stock Warrants [Member]
Weighted Average Fair Value	$ 1.38	$ 0
Selling, General And Administrative Expenses	504,777	0
Stock-Based Compensation Expense	$ 674,312
Weighted Average Remaining Period	2 years 6 months
Warrants Exercise Purchase	11,840,859